Levels of pyrrolizidine alkaloids in herbal teas and teas are too high
The first non-representative results of a BfR research project show that efforts are required to minimise levels
“We measured unexpectedly high levels of pyrrolizidine alkaloids in some of the tea and herbal tea samples,” says BfR President Professor Dr. Dr. Andreas Hensel. “As data from animal experiments uncovered the detected pyrrolizidine alkaloids as genotoxic carcinogens, the levels are too high and should possibly be reduced”
These include analysis of tea and herbal tea batches prior to marketing but also causal research by the economic operators. Despite the unexpectedly high levels in some of the samples, acute health damage to adults and children is unlikely if consumed over short periods. If, however, higher than average consumption of products currently measured with medium and high levels of pyrrolizidine alkaloids is maintained over longer periods, a risk to health could result, especially for children, pregnant women and nursing mothers if the current data is validated. Because there are considerable fluctuations in the concentrations of individual samples, however, even with teas of the same variety, it is currently impossible to make a definite statement regarding the health risk resulting from continous intake of contaminated tea infusions. Our initial recommendation is therefore that parents do not exclusively give their children tea and herbal tea. Expectant and nursing mothers should also consume tea and herbal tea alternately with other beverages. The first data collected in the research project have to be be verified by Food monitoring authorities.
Most read news
Other news from the department science
Get the analytics and lab tech industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.